In EGPA G-CSF, GM-CSF, IL-6, IL-15 and sIL-2Rα showed significant increases during active disease, as did BCA-1/CXCL13 but only after adjustment for treatment. This evidence concerns the gene CSF3 and eosinophilic granulomatosis with polyangiitis.